ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes

Affiliations

¹ Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
² Department of Pediatrics, Ain Shams University, Cairo, Egypt.
³ Barbara Davis Center for Diabetes, University of Colorado, Denver, Colorado, USA.
⁴ Division of Endocrinology and Diabetes, Department of Pediatrics, Stanford University Medical Center, Stanford, California, USA.
⁵ Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
⁶ Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Herlev and Steno Diabetes Center Copenhagen, Copenhagen, Denmark.
⁷ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
⁹ Parent/Advocate for people with diabetes, Markham, Canada.
¹⁰ Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Elke Fröhlich-Reiterer et al. Pediatr Diabetes. 2022 Dec.

. 2022 Dec;23(8):1451-1467.

doi: 10.1111/pedi.13445.

¹ Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
² Department of Pediatrics, Ain Shams University, Cairo, Egypt.
³ Barbara Davis Center for Diabetes, University of Colorado, Denver, Colorado, USA.
⁴ Division of Endocrinology and Diabetes, Department of Pediatrics, Stanford University Medical Center, Stanford, California, USA.
⁵ Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
⁶ Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Herlev and Steno Diabetes Center Copenhagen, Copenhagen, Denmark.
⁷ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
⁹ Parent/Advocate for people with diabetes, Markham, Canada.
¹⁰ Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Keywords: autoimmune comorbidities; bone health; celiac disease; growth and development; skin disorders; thyroid; type 1 diabetes.

References

1. Lamb MM, Yin X, Zerbe GO, et al. Height growth velocity, islet autoimmunity and type 1 diabetes development: the diabetes autoimmunity study in the young. Diabetologia. 2009;52(10):2064-2071.
1. Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith GJ, Dabelea D. Childhood growth and age at diagnosis with type 1 diabetes in Colorado young people. Diabet Med. 2009;26(10):961-967.
1. Islam ST, Abraham A, Donaghue KC, et al. Plateau of adiposity in Australian children diagnosed with type 1 diabetes: a 20-year study. Diabet Med. 2014;31(6):686-690.
1. Beyerlein A, Thiering E, Pflueger M, et al. Early infant growth is associated with the risk of islet autoimmunity in genetically susceptible children. Pediatr Diabetes. 2014;15(7):534-542.
1. Liu X, Vehik K, Huang Y, et al. Distinct growth phases in early life associated with the risk of type 1 diabetes: the TEDDY study. Diabetes Care. 2020;43(3):556-562.